| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/07/2010 | US20100003265 Isolation, expansion and uses of tumor stem cells |
| 01/07/2010 | US20100003259 Antibodies that immunospecifically bind to b lymphocyte stimulator protein |
| 01/07/2010 | US20100003258 Fibroblast growth factor receptor 3 (fgfr3) binding proteins |
| 01/07/2010 | US20100003255 Gene expression pattern predictive for colorectal carcinomas |
| 01/07/2010 | US20100003251 Uses of IL-23 Agonists and Antagonists; Related Reagents |
| 01/07/2010 | US20100003250 (2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/07/2010 | US20100003249 Polypeptide constructs for topical administration |
| 01/07/2010 | US20100003248 Polypeptide constructs for rectal and/or vaginal administration |
| 01/07/2010 | US20100003247 Assay for metastatic colorectal cancer |
| 01/07/2010 | US20100003246 Novel heterocyclic compounds and uses therof |
| 01/07/2010 | US20100003240 Cancer treatment with endothelin receptor antagonists |
| 01/07/2010 | US20100003238 Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions |
| 01/07/2010 | US20100003221 Medium Supplement for Virus Production |
| 01/07/2010 | US20100003220 Agents for treating malignant mesothelioma |
| 01/07/2010 | US20100003197 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof |
| 01/07/2010 | US20100003192 Treatment of breast cancer with a parp inhibitor alone or in combination with anti-tumor agents |
| 01/07/2010 | US20100003189 Cancer biomarkers and methods of use thereof |
| 01/07/2010 | CA2729868A1 Anti- p2x7 peptides and epitopes |
| 01/07/2010 | CA2729775A1 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 01/07/2010 | CA2729757A1 Methods for treating neoplasia by inhibiting lactate dehydrogenase and/or nicotinamide phosphoribosyltransferase |
| 01/07/2010 | CA2729745A1 Oxindole compounds |
| 01/07/2010 | CA2729725A1 Pyrrolopyridinylpyrimidin-2-ylamine derivatives |
| 01/07/2010 | CA2729710A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities |
| 01/07/2010 | CA2729690A1 Novel pyrrolo [2,3-a] carbazoles and use thereof as pim kinase inhibitors |
| 01/07/2010 | CA2729620A1 Antitumoral macrolides |
| 01/07/2010 | CA2729567A1 Anti-cd27 antibody |
| 01/07/2010 | CA2729557A1 Chemical compounds 251 |
| 01/07/2010 | CA2729499A1 Anti-gd2 antibodies and methods and uses related thereto |
| 01/07/2010 | CA2729412A1 Novel spirochromanone carboxylic acids |
| 01/07/2010 | CA2729403A1 Anti-cdh3 antibodies labeled with radioisotope label and uses thereof |
| 01/07/2010 | CA2729369A1 Method |
| 01/07/2010 | CA2729343A1 Topical steroidal formulations |
| 01/07/2010 | CA2729110A1 Isolation of cyclopamine |
| 01/07/2010 | CA2728769A1 Nitrogen heterocycle derivatives as proteasome modulators |
| 01/07/2010 | CA2728762A1 Rna antagonists targeting hsp27 |
| 01/07/2010 | CA2728559A1 Cdk modulators |
| 01/07/2010 | CA2728301A1 Vinpocetine and eburnamonine derivatives for promoting bone growth |
| 01/07/2010 | CA2728219A1 Diglycidic ether derivative therapeutics and methods for their use |
| 01/07/2010 | CA2727252A1 Isoindolone derivatives as mek kinase inhibitors and methods of use |
| 01/07/2010 | CA2727250A1 Bicyclic heterocycles as mek kinase inhibitors |
| 01/07/2010 | CA2727103A1 Naphthyridinones as aurora kinase inhibitors |
| 01/07/2010 | CA2726040A1 Quinazoline derivatives |
| 01/06/2010 | EP2141234A1 Short Interfering RNA (siRNA) Analogues |
| 01/06/2010 | EP2141231A1 METHOD FOR INHIBITION OF SIGNALING THROUGH ErbB2, SIGNALING INHIBITOR FOR USE IN THE METHOD, AND USE OF THE SIGNALING INHIBITOR |
| 01/06/2010 | EP2141163A1 Substituted thiazolidinones, their production and utilisation as medicine |
| 01/06/2010 | EP2141146A1 Calcilytic compounds |
| 01/06/2010 | EP2140879A1 Composition and method for treating cancer using herpes virus |
| 01/06/2010 | EP2139994A2 2786, a human aminopeptidase |
| 01/06/2010 | EP2139923A1 Modulation of tumor microenvironment |
| 01/06/2010 | EP2139922A1 Treatment of hodgkins lymphoma |
| 01/06/2010 | EP2139920A1 Human anti cd166 antibody binding human tumor cells |
| 01/06/2010 | EP2139917A2 Anti-androgen peptides and uses thereof in cancer therapy |
| 01/06/2010 | EP2139913A2 Inducing immune-mediated tumor cell death |
| 01/06/2010 | EP2139869A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| 01/06/2010 | EP2139856A1 Substituted 3-(4-hydroxyphenyl)-indolin-2-one-compounds |
| 01/06/2010 | EP2139850A1 Inhibitors of histone deacetylase |
| 01/06/2010 | EP2139524A1 Multivalent heterobifunctional polymers and methods of their use |
| 01/06/2010 | EP2139522A2 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers |
| 01/06/2010 | EP2139508A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/06/2010 | EP2139490A2 Diazo bicyclic smac mimetics and the uses thereof |
| 01/06/2010 | EP2139482A1 Treatment for multiple myeloma |
| 01/06/2010 | EP2139465A1 Composition comprising s-allylmercapto-n-acetylcysteine (assnac) for up-regulation of cellular glutathione level |
| 01/06/2010 | EP2139331A1 Compositions and methods relating to novel compounds and targets thereof |
| 01/06/2010 | EP2139329A1 Novel imidazo based heterocycles |
| 01/06/2010 | EP2139325A2 Anti-angiogenic agents and methods of use |
| 01/06/2010 | EP1885364B1 Halogenated quindoline dimers for the treatment of cancer |
| 01/06/2010 | EP1635835B1 2-aminopyrimidine derivatives as raf kinase inhibitors |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1135468B1 Virus vectors and methods of making and administering the same |
| 01/06/2010 | EP1032417B1 Bacterial vaccines comprising auxotrophic, attenuated strains of listeria expressing heterologous antigens |
| 01/06/2010 | EP1005361B1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ENDOTHELIAL DYSFUNKTION AND FOR THE INHIBITION OF ANGIOGENESIS RESPECTIVELY |
| 01/06/2010 | CN101618049A Treatment of neoplasms with viruses |
| 01/06/2010 | CN100578227C TTK in diagnosis and as a therapeutic target in cancer |
| 01/06/2010 | CN100577685C Long-acting thymosin alpha1 polyethylene glycol modifier |
| 01/06/2010 | CN100577677C Caulis trachelospermi total lignans extractive, extraction method and medicine use of the active constituent thereof |
| 01/06/2010 | CN100577672C Ruthenium-anthraquinone conjugates, preparation method thereof and application for the same used as optical power therapeutic photosensitizer |
| 01/06/2010 | CN100577665C Antineoplastic active canthardin derivative and method for preparing same |
| 01/06/2010 | CN100577658C 喹唑啉衍生物 Quinazoline derivatives |
| 01/06/2010 | CN100577631C Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA-damaging treatments |
| 01/06/2010 | CN100577213C Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 01/06/2010 | CN100577209C Magnetic tumor double-target polymer nano micelle and preparation thereof |
| 01/06/2010 | CN100577208C Technique for preparing embolism agent of granule of polyvinyl formal |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/06/2010 | CN100577203C Use of urease for inhibiting cancer cell growth |
| 01/06/2010 | CN100577190C Medicine for treating cancer |
| 01/06/2010 | CN100577182C Emulsion containing aucklandia root oil, its preparation process and use |
| 01/06/2010 | CN100577180C Application of gambogicacid in preparing medication for restraining angiogenesis |
| 01/06/2010 | CN100577177C Medical combination of teniposide, the preparing method and use thereof |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577167C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 01/06/2010 | CN100577146C Self-emulsion preparation of glossy ganoderma spore oil and preparation method thereof |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642284 Luminacin analogs and uses thereof |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642266 cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 01/05/2010 | US7642255 Compounds and compositions as protein kinase inhibitors |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | US7642229 Synergistic antineoplastic effect; side effect reduction |
| 01/05/2010 | US7642054 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 01/05/2010 | US7641905 Methods of inducing an immune response |